Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Marathon Digital Holdings Inc (MARA) vs Medtronic PLC (MDT) Price & Performance

Marathon Digital Holdings IncTrade
Medtronic PLCTrade

Price performance (Past 24H)

Key statistics

Marathon Digital Holdings Inc vs Medtronic PLC — how do they compare? Marathon Digital Holdings Inc trades at $9.73 (market cap $3.83B), while Medtronic PLC trades at $89.16 (market cap $112.24B). The key difference: Medtronic PLC is far larger — about 29.3× Marathon Digital Holdings Inc's market cap, and Medtronic PLC pays a 3.28% dividend while Marathon Digital Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Marathon Digital Holdings Inc for 22 Days and Medtronic PLC for 63 Days on average.

MARAMDT
Market Cap
$3.83B$112.24B
Volume
47,742,698105,663,236
Sector
FinancialsHealth
52-Week High
$22.84$105.35
52-Week Low
$6.73$73.75
Typical Hold Time
22 Days63 Days
Enterprise Value
$5.87B$131.58B
Dividend Yield
—3.28%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Marathon Digital Holdings Inc

MARA stock trades at $9.71, down 6.27% on the day, reflecting a volatile trend. The technical outlook is bearish overall, with moving averages signaling a downtrend, though oscillators suggest potential for a short-term bounce. Fundamentally, the company reported a net loss of $1.31 billion in 2025 with a negative net income margin of -429.71%, despite a high gross margin of 76.71%. Recent earnings have consistently missed expectations, with Q2 2026 EPS of -1.6 missing the expected 0.1666. Analyst sentiment is mixed, with a consensus price target of $13.25.

The outlook for MARA is challenged by persistent losses and negative profitability metrics, though low valuation ratios like a P/E of 3.37 may attract value investors. Key risks include execution challenges in achieving profitability, high cash burn from operations, and sensitivity to broader market sentiment. The stock's performance remains heavily influenced by news flow and sector momentum, requiring careful risk assessment for potential investors.

Medtronic PLC

Medtronic (MDT) trades at $85.51, down 1.81% on the day, with the stock showing bearish technical signals despite strong fundamental performance. The company has beaten earnings expectations for three consecutive quarters, maintains a healthy 13.93% net income margin, and offers a solid 3.2% dividend yield with 49 consecutive years of dividend growth. Recent positive developments include FDA clearances for new medical technologies and raised full-year guidance.

MDT presents a compelling value opportunity with analyst consensus pointing to 14% upside to the $97.80 price target. The stock's current valuation multiples (P/E 21.61, P/S 3.01) appear reasonable given the company's stable revenue growth and strong cash flow generation. Key risks include increasing debt levels and competitive pressures in the medical device sector, but the company's dividend aristocrat status and improving operational performance support a positive long-term outlook.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MARA
99% Buy1% Sell
Avg holding period · 22 Days
MDT
53% Buy47% Sell
Avg holding period · 63 Days

Top news

Latest headlines on both assets

About Marathon Digital Holdings Inc

Marathon Digital Holdings, Inc. is one of the largest publicly traded Bitcoin mining companies in North America. The company focuses on building and operating large-scale, cost-efficient Bitcoin mining facilities. Marathon's strategy centers on increasing its mining hash rate and using sustainable energy sources to expand its Bitcoin production. The company's performance is closely tied to the price of Bitcoin and the overall health of the digital asset mining industry.

Read more on MARA →

About Medtronic PLC

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.

Read more on MDT →